Testosterone as a Biomarker of Adverse Clinical Outcomes in SARS-CoV-2 Pneumonia

MLA

Lorenzo Marinelli, et al. “Testosterone as a Biomarker of Adverse Clinical Outcomes in SARS-CoV-2 Pneumonia.” Biomedicines, vol. 10, no. 4, Mar. 2022, p. 820. EBSCOhost, https://doi.org/10.3390/biomedicines10040820.

APA

Lorenzo Marinelli, Guglielmo Beccuti, Marco Zavattaro, Serena Cagnina, Iacopo Gesmundo, Chiara Bona, Chiara Lopez, Silvia Scabini, Francesca Canta, Simone Mornese Pinna, Tommaso Lupia, Cataldo Di Bisceglie, Federico Ponzetto, Fabio Settanni, Francesco Giuseppe De Rosa, Ezio Ghigo, & Giovanna Motta. (2022). Testosterone as a Biomarker of Adverse Clinical Outcomes in SARS-CoV-2 Pneumonia. Biomedicines, 10(4), 820. https://doi.org/10.3390/biomedicines10040820

Chicago

Lorenzo Marinelli, Guglielmo Beccuti, Marco Zavattaro, Serena Cagnina, Iacopo Gesmundo, Chiara Bona, Chiara Lopez, et al. 2022. “Testosterone as a Biomarker of Adverse Clinical Outcomes in SARS-CoV-2 Pneumonia.” Biomedicines 10 (4): 820. doi:10.3390/biomedicines10040820.